Haemonetics Corp’s recent filing unveils that its Former Officer Lingamneni Anila acquired Company’s shares for reported $0.57 million on Nov 11 ’24. In the deal valued at $90.68 per share,6,238 shares were bought.
Then, Strong Stewart W sold 4,312 shares, generating $393,039 in total proceeds. Upon selling the shares at $91.15, the President, Global Hospital now owns 18,196 shares.
Before that, Strong Stewart W bought 4,312 shares. Haemonetics Corp shares valued at $393,039 were divested by the Officer at a price of $91.15 per share.
JP Morgan initiated its Haemonetics Corp [HAE] rating to an Overweight in a research note published on December 06, 2024; the price target was $116. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in early November from “an Outperform” to “a Strong buy”. CL King began covering HAE with “Buy” recommendation on September 13, 2024. BofA Securities started covering the stock on September 11, 2024. It rated HAE as “a Neutral”.
Price Performance Review of HAE
On Tuesday, Haemonetics Corp [NYSE:HAE] saw its stock jump 0.30% to $77.41. Over the last five days, the stock has lost -5.68%. Haemonetics Corp shares have fallen nearly -9.47% since the year began. Nevertheless, the stocks have fallen -12.03% over the past one year. While a 52-week high of $97.97 was reached on 05/15/24, a 52-week low of $70.25 was recorded on 10/31/24. SMA at 50 days reached $81.21, while 200 days put it at $82.86.
Levels Of Support And Resistance For HAE Stock
The 24-hour chart illustrates a support level at 76.17, which if violated will result in even more drops to 74.92. On the upside, there is a resistance level at 78.10. A further resistance level may holdings at 78.78. The Relative Strength Index (RSI) on the 14-day chart is 38.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.72, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.22%. Stochastics %K at 19.18% indicates the stock is a buying.
How much short interest is there in Haemonetics Corp?
A steep rise in short interest was recorded in Haemonetics Corp stocks on 2024-11-29, dropping by -0.59 million shares to a total of 4.57 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 5.16 million shares. There was a decline of -13.01%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 10, 2024 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $112 price target.
